BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17949684)

  • 21. An integrated map of p53-binding sites and histone modification in the human ENCODE regions.
    Kaneshiro K; Tsutsumi S; Tsuji S; Shirahige K; Aburatani H
    Genomics; 2007 Feb; 89(2):178-88. PubMed ID: 17085012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
    Mannefeld M; Klassen E; Gaubatz S
    Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human 8-oxoguanine DNA glycosylase suppresses the oxidative stress induced apoptosis through a p53-mediated signaling pathway in human fibroblasts.
    Youn CK; Song PI; Kim MH; Kim JS; Hyun JW; Choi SJ; Yoon SP; Chung MH; Chang IY; You HJ
    Mol Cancer Res; 2007 Oct; 5(10):1083-98. PubMed ID: 17951408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling by microarray analysis reveals an important role for caspase-1 in dengue virus-induced p53-mediated apoptosis.
    Nasirudeen AM; Liu DX
    J Med Virol; 2009 Jun; 81(6):1069-81. PubMed ID: 19382257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
    Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
    Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide DNA replication profile for Drosophila melanogaster: a link between transcription and replication timing.
    Schübeler D; Scalzo D; Kooperberg C; van Steensel B; Delrow J; Groudine M
    Nat Genet; 2002 Nov; 32(3):438-42. PubMed ID: 12355067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines.
    Shaked H; Shiff I; Kott-Gutkowski M; Siegfried Z; Haupt Y; Simon I
    Cancer Res; 2008 Dec; 68(23):9671-7. PubMed ID: 19047144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Of flies and men; p53, a tumour suppressor.
    Sutcliffe JE; Brehm A
    FEBS Lett; 2004 Jun; 567(1):86-91. PubMed ID: 15165898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage.
    Liu Z; Liu Q; Xu B; Wu J; Guo C; Zhu F; Yang Q; Gao G; Gong Y; Shao C
    Mutat Res; 2009 Mar; 662(1-2):75-83. PubMed ID: 19159633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excision of nucleoside analogs in mitochondria by p53 protein.
    Bakhanashvili M; Grinberg S; Bonda E; Rahav G
    AIDS; 2009 Apr; 23(7):779-88. PubMed ID: 19287302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Replication timing during S phase and GC% distribution of human genome: disease-related genes found in transition regions of replication timing].
    Watanabe Y; Ikemura T
    Tanpakushitsu Kakusan Koso; 2001 Dec; 46(16 Suppl):2371-4. PubMed ID: 11802396
    [No Abstract]   [Full Text] [Related]  

  • 32. A functional analysis of p53 during early development of Xenopus laevis.
    Amariglio F; Tchang F; Prioleau MN; Soussi T; Cibert C; Méchali M
    Oncogene; 1997 Oct; 15(18):2191-9. PubMed ID: 9393977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNFalpha-induced activation of NFkappaB protects against UV-induced apoptosis specifically in p53-proficient cells.
    Szołtysek K; Pietranek K; Kalinowska-Herok M; Pietrowska M; Kimmel M; Widłak P
    Acta Biochim Pol; 2008; 55(4):741-8. PubMed ID: 19023456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle control and cancer chemotherapy.
    Kohn KW; Jackman J; O'Connor PM
    J Cell Biochem; 1994 Apr; 54(4):440-52. PubMed ID: 8014193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomere dysfunction and loss of p53 cooperate in defective mitotic segregation of chromosomes in cancer cells.
    Pantic M; Zimmermann S; El Daly H; Opitz OG; Popp S; Boukamp P; Martens UM
    Oncogene; 2006 Jul; 25(32):4413-20. PubMed ID: 16547498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
    Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asynchronous replication of alleles in genomes carrying a microdeletion.
    Amiel A; Reish O; Gaber E; Masterman R; Tohami T; Fejgin MD
    Isr Med Assoc J; 2002 Sep; 4(9):702-5. PubMed ID: 12440235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton induces apoptosis of hypoxic tumor cells by the p53-dependent and p38/JNK MAPK signaling pathways.
    Lee KB; Kim KR; Huh TL; Lee YM
    Int J Oncol; 2008 Dec; 33(6):1247-56. PubMed ID: 19020758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
    Konstantakou EG; Voutsinas GE; Karkoulis PK; Aravantinos G; Margaritis LH; Stravopodis DJ
    Int J Oncol; 2009 Aug; 35(2):401-16. PubMed ID: 19578756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The tumor suppressor gene p53 (part one). Structure, function and mechanisms of inactivation].
    Martin A
    Ann Pathol; 1995; 15(3):178-83. PubMed ID: 7639853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.